A comparison of misoprostol with and without methylergometrine and oxytocin in outpatient medical abortion: a phase III randomized controlled trial. [PDF]
BMC Res Notes, 2023 Jahromi AR +3 more
europepmc +1 more source
Women's real-time pain and stress during medical abortion: An ecological momentary assessment study. [PDF]
Acta Obstet Gynecol ScandFelnhofer A +5 more
europepmc +1 more source
Home use of mifepristone for medical abortion: a systematic review. [PDF]
BMJ Sex Reprod HealthGemzell-Danielsson K +6 more
europepmc +1 more source
Short-term efficacy and safety of early medical abortion in Japan: A multicenter prospective study. [PDF]
Reprod Med Biol, 2023 Osuga Y +3 more
europepmc +1 more source
Ultrasound-derived gestational sac triple product as a predictor of early medical abortion failure with mifepristone-misoprostol regimens: a retrospective cohort study. [PDF]
Front Med (Lausanne)Xue RH +8 more
europepmc +1 more source
Pain management for medical abortion before 14 weeks' gestation. [PDF]
Cochrane Database Syst Rev, 2022 Reynolds-Wright JJ +3 more
europepmc +1 more source
Comparative analysis of social issues toward medical abortion using mifepristone in South Korea and the United States: Topic modeling and sentiment analysis. [PDF]
PLoS OneKo M, Park DY, Oh JM, Song YK.
europepmc +1 more source
Pathways to medical abortion self-use (MASU): results from a cross-sectional survey of women's experiences in Kenya and Uganda. [PDF]
BMC Womens Health, 2023 Ouma OJ +4 more
europepmc +1 more source
Self-managed medical abortion in Nigeria: a prospective, comparative study of clinical outcomes for a misoprostol-alone regimen obtained from patent medicine vendors compared to clinics. [PDF]
Reprod HealthShellenberg KM +5 more
europepmc +1 more source
Mate Whenua-follow-up after early medical abortion: study protocol for a randomized controlled trial. [PDF]
TrialsWise MR +9 more
europepmc +1 more source